Protagonist Therapeutics, Inc. <PTGX.O>: H.C. Wainwright raises target price to $167 from $117
PTGX•Related News
Eiffage reports BlackRock beneficial stake at 6.13%
BLK•
Starbucks manager's comments to unionized worker were lawful, NLRB rules
SBUX•
U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson
CAT•
FVCBankcorp Q2 FY26 net income climbs 45% to $8.2 million; revenue rises 32% to $21.3 million
FVCB•
Marqeta expands collaboration with Google on Wallet for kids payments offering
MQ•